Nail loss might represent a new, reversible, adverse event associated with teriflunomide treatment. It shares close analogies with hair loss and thinning, known adverse events of teriflunomide. MS specialists should be aware of this possibility and evaluate treatment discontinuation.
Nail loss after teriflunomide treatment: A new potential adverse event / Mancinelli, L.; Amerio, P.; di Ioia, M.; Di Tommaso, V.; De Luca, G.; Onofrj, M.; Lugaresi, A.. - In: MULTIPLE SCLEROSIS AND RELATED DISORDERS. - ISSN 2211-0348. - ELETTRONICO. - 18:(2017), pp. 170-172. [10.1016/j.msard.2017.09.029]
Nail loss after teriflunomide treatment: A new potential adverse event
MANCINELLI, LUCA;Lugaresi, A.
2017
Abstract
Nail loss might represent a new, reversible, adverse event associated with teriflunomide treatment. It shares close analogies with hair loss and thinning, known adverse events of teriflunomide. MS specialists should be aware of this possibility and evaluate treatment discontinuation.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
